v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ (1,243,521) $ 2,122,189
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation 6,470 6,469
Stock based compensation 344,063 679,268
Amortization of debt discounts 284,010 145,038
Gain on change in fair value of derivative liabilities (476,973) (4,109,195)
Loss on settlement of liabilities 230,726 46,346
Changes in assets and liabilities:    
Prepaid expenses 11,363 20,808
Accounts payable and accrued expenses 55,165 68,220
Accrued expenses to related party 8,308 938
Cash flows used in operating activities: (780,389) (1,019,919)
Cash flows from financing activities:    
Proceeds from advances, related party 75,000 354,693
Repayments of advances, related party (280,000) (25,000)
Proceeds from advances 9,000
Repayments of advances (9,000)
Repayments of notes payable (24,750) (24,750)
Proceeds from notes payable, related party 467,000
Repayments of notes payable, related party (273,175) (55,000)
Proceeds from convertible promissory notes 719,950 336,000
Repayments of convertible promissory notes (123,860) (184,080)
Proceeds from the issuance of common stock for cash, net 885,177 90,919
Proceeds from the issuance of common stock and warrants in a private placement 67,044
Net cash provided by financing activities 1,036,386 968,782
Increase (decrease) in cash and cash equivalents 255,997 (51,137)
Cash and cash equivalents, beginning of period 20,962 72,099
Cash and cash equivalents, end of period 276,959 20,962
Supplemental disclosure of cash flow information:    
Income tax paid
Interest paid 49,028 948
Supplemental disclosure of non-cash items:    
Shares issued for conversion of debt and interest 486,286 114,400
Prepaid insurance financed with note payable 24,750 24,750
Settlement of subscription and interest receivable 17,230
Issuance of common stock and warrants in private placement for settlement of liabilities 514,128 124,693
Resolution of derivative liabilities due to debt conversions 156,837 52,476
Debt discounts due to derivative liabilities 158,809 67,352
Reclass of APIC to derivative liabilities for tainted warrants 216,638 1,858,199
Shares issued for deferred financing costs 20,000
Reclassification of deferred financing costs to equity $ 20,000